Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$393,564
+$63,632 QoQ
Shares Held
1,564
+3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#3,387
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. ABBV ranks #7 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
1,564 | $393,564 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $393,564 | 1,564 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $329,932 | 1,517 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $363,984 | 1,593 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $445,946 | 1,926 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $352,678 | 1,900 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $432,239 | 2,063 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $304,577 | 1,714 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $340,060 | 1,722 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $312,680 | 1,823 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $384,048 | 2,109 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $293,668 | 1,895 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $281,872 | 1,891 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $276,196 | 2,050 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $365,594 | 2,294 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,990,730 | 61,820 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,085,749 | 60,247 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,135,534 | 59,647 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,792,383 | 109,755 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $15,122,826 | 111,690 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $11,611,450 | 107,643 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $11,500,544 | 102,100 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $11,049,262 | 102,100 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $10,705,570 | 99,912 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $8,789,130 | 100,344 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $9,932,772 | 101,169 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,826,693 | 102,726 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||